他汀类药物诱导的抗HMGCR免疫介导坏死性肌病中不寻常的皮肤受累情况 - Suppr

Suppr

超能文献

Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy.

作者信息

Scard Camille, Bara-Passot Corina, Chassain Kévin, Maillard Hervé

机构信息

Department of Dermatology, Le Mans Hospital Center, 194, Avenue Rubillard, FR-72037 Le Mans, France. E-mail:

出版信息

Acta Derm Venereol. 2021 Mar 17;101(3):adv00415. doi: 10.2340/00015555-3645.

DOI:10.2340/00015555-3645

PMID:32985673

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9366499/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1283/9366499/1813b168973f/ActaDV-101-3-966-g001.jpg

相似文献

Unusual Skin Involvement in Statin-induced Anti-HMGCR Immune-mediated Necrotizing Myopathy.他汀类药物诱导的抗HMGCR免疫介导坏死性肌病中不寻常的皮肤受累情况

Acta Derm Venereol. 2021 Mar 17;101(3):adv00415. doi: 10.2340/00015555-3645.

[Two cases of statin-induced immune-mediated necrotizing myopathy].[两例他汀类药物诱导的免疫介导性坏死性肌病]

Lakartidningen. 2021 Dec 1;118:21110.

Therapeutic challenges and cardiovascular risk in patients with HMGCR-associated immune-mediated necrotizing myopathy (HMGR-IMNM) secondary to statins.他汀类药物继发的HMGCR相关免疫介导坏死性肌病（HMGR-IMNM）患者的治疗挑战与心血管风险

Eur J Intern Med. 2023 Aug;114:143-145. doi: 10.1016/j.ejim.2023.05.011. Epub 2023 May 12.

[Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].以抗HMGCR抗体为特征的他汀类药物诱导的坏死性自身免疫性肌病表现为皮肌炎样综合征

Ann Dermatol Venereol. 2019 Sep;146(8-9):550-556. doi: 10.1016/j.annder.2018.12.010. Epub 2019 Mar 29.

Statin-induced autoimmune necrotizing myopathy with pharyngeal muscles involvement.他汀类药物诱导的自身免疫性坏死性肌病伴咽肌受累。

Age Ageing. 2020 Aug 24;49(5):883-884. doi: 10.1093/ageing/afaa038.

Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.他汀类药物相关性自身免疫性肌病与抗 HMGCR 自身抗体。

Muscle Nerve. 2013 Oct;48(4):477-83. doi: 10.1002/mus.23854. Epub 2013 Aug 30.

Diagnosis of Statin-Induced Necrotizing Myopathy: Contribution of Anti-HMGCR Antibodies.他汀类药物诱导的坏死性肌病的诊断：抗 HMGCR 抗体的作用。

Acta Med Port. 2022 Jul 1;35(7-8):584-587. doi: 10.20344/amp.16181. Epub 2021 Sep 30.

Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.抗3-羟基-3-甲基戊二酰辅酶A还原酶（HMGCR）抗体在他汀类药物暴露后免疫介导的坏死性肌病的诊断中显示出高诊断价值。

Immunol Res. 2017 Feb;65(1):276-281. doi: 10.1007/s12026-016-8867-x.

Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.免疫介导的肌病与抗 3-羟基-3-甲基戊二酰辅酶 A 还原酶抗体有关，是他汀类药物引起的坏死性肌病的一个新出现的原因。

Joint Bone Spine. 2014 Jan;81(1):79-82. doi: 10.1016/j.jbspin.2013.06.008. Epub 2013 Aug 13.

Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies.他汀类药物诱导的免疫介导性坏死性肌病伴抗 HMGCR 和抗 ACHR 抗体增加。

Rheumatol Int. 2024 May;44(5):955-959. doi: 10.1007/s00296-024-05559-8. Epub 2024 Mar 10.

引用本文的文献

Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase immune-mediated necrotizing myopathy with a CD68+ lymphohistiocytic cutaneous eruption.伴有CD68+淋巴细胞组织细胞性皮肤疹的抗3-羟基-3-甲基戊二酰辅酶A还原酶免疫介导坏死性肌病

JAAD Case Rep. 2025 Feb 22;59:16-18. doi: 10.1016/j.jdcr.2025.01.027. eCollection 2025 May.

Atypical skin conditions of the neck and back as a dermal manifestation of anti-HMGCR antibody-positive myopathy.抗 HMGCR 抗体阳性肌病的皮肤表现为颈部和背部的非典型皮肤状况。

BMC Immunol. 2024 May 11;25(1):30. doi: 10.1186/s12865-024-00622-2.

A case of anti-HMGCR myopathy in a patient with breast cancer and anti-Th/To antibodies.一名患有乳腺癌且有抗Th/To抗体的患者发生抗3-羟基-3-甲基戊二酰辅酶A还原酶（HMGCR）肌病的病例。

Oxf Med Case Reports. 2023 Sep 25;2023(9):omad097. doi: 10.1093/omcr/omad097. eCollection 2023 Sep.

Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy.他汀类药物治疗五年后出现的免疫介导性坏死性肌病。

Case Rep Rheumatol. 2023 Apr 24;2023:1178035. doi: 10.1155/2023/1178035. eCollection 2023.

本文引用的文献

Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study.瑞典特发性炎性肌病的发病率和患病率：一项基于全国人口的研究。

Rheumatology (Oxford). 2017 May 1;56(5):802-810. doi: 10.1093/rheumatology/kew503.

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.抗 HMGCR 抗体作为免疫介导性坏死性肌病的生物标志物：他汀类药物的历史和来自大型国际多中心研究的经验。

Autoimmun Rev. 2016 Oct;15(10):983-93. doi: 10.1016/j.autrev.2016.07.023. Epub 2016 Aug 1.

Statins and myositis: the role of anti-HMGCR antibodies.他汀类药物与肌炎：抗HMGCR抗体的作用

Expert Rev Clin Immunol. 2015;11(12):1277-9. doi: 10.1586/1744666X.2015.1102632. Epub 2015 Oct 22.

Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.皮肌炎的皮肤表现：关键临床和血清学特征——全面综述

Clin Rev Allergy Immunol. 2016 Dec;51(3):293-302. doi: 10.1007/s12016-015-8496-5.

Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin.欧洲自身免疫性坏死性肌病患者中的抗HMGCR自身抗体：他汀类药物的非持续暴露

Medicine (Baltimore). 2014 May;93(3):150-157. doi: 10.1097/MD.0000000000000028.

Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.成人多发性肌炎和皮肌炎的患病率和临床特征；来自一个大型且未选择的挪威队列的数据。

Ann Rheum Dis. 2015 Aug;74(8):1551-6. doi: 10.1136/annrheumdis-2013-205127. Epub 2014 Apr 2.

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.他汀类药物相关性自身免疫性肌病患者中抗3-羟基-3-甲基戊二酰辅酶A还原酶自身抗体

Arthritis Rheum. 2011 Mar;63(3):713-21. doi: 10.1002/art.30156.

A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.一种识别200kd和100kd蛋白质的新型自身抗体与免疫介导的坏死性肌病相关。

Arthritis Rheum. 2010 Sep;62(9):2757-66. doi: 10.1002/art.27572.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验